Cyclosporine levels impact early rejection episodes.
Granger
D K
DK
Department of Surgery, University of Minnesota, Minneapolis.
Amin
N B
NB
Sorenson
A L
AL
Gillingham
K J
KJ
Canafax
D M
DM
Matas
A J
AJ
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000097:blood* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone